Deutsch
TU Dresden

search
Paul Ehrlich- and Ludwig Darmstaedter Prize for Young Researchers 2017 for Dr. Volker Busskamp
CRTD group leader Dr. Volker Busskamp will receive the Paul Ehrlich- and Ludwig Darmstaedter Prize for Young Researchers on March 14, 2017.  [read more]
Dr. Volker Busskamp © 2016 Sven Döring
Already more than 600 participants in Freder1k study at University Hospital Carl Gustav Carus Dresden (UKD)
Since September 2016, already 615 newborns participated in the Freder1k study, which is led by CRTD Director Prof. Ezio Bonifacio, PhD. [read more]
Prof. Pauline Wimberger (right) and Dr. Katharina Nitzsche (both UKD) © Stephan Wiegand, MF TUD
Support for translational research: Europe wide cooperation on spinal cord injury research receives 1.34 Million Euros grant
Six European research teams including Dr. Michell Reimer and his team at the CRTD received a 1.34 Million Euros ERA NET NEURON Grant for their research on spinal cord injury. [read more]
Cross section of the zebrafish spinal cord. Radial glia is labelled by IHC. © Dr. Volker Kroehne (Reimer Lab)
Dynamics and mechanisms of cell renewal: Dr. Olaf Bergmann supports neurodegeneration research at the CRTD
On November 1st 2016, Dr. Olaf Bergmann started as a research group leader at the CRTD. Dr. Bergmann focuses on organ systems that show a low level of regenerative capacity, such as the human brain... [read more]
© Ting-Di Wu, Jean-Luc Guerquin-Kern, Olaf Bergmann


At the DFG-Center for Regenerative Therapies Dresden (CRTD), our mission is to understand the biology of stem cells and physiological and pathological tissue and organ repair in order to develop new treatments for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, haematological diseases, such as leukemia, metabolic diseases, such as diabetes, and bone diseases. Our scientists are encouraged to think outside the box and to explore untapped areas of knowledge in the regenerative potential of the human body, and to apply this knowledge to prevent or reverse disease processes.

To achieve our aims, we strongly support interdisciplinary research, with eighteen core groups in a network of 87 principal investigators from diverse research institutes on the Dresden campus, with expertise in everything from the biology of cells and tissues to biomaterials to nanoengineering. CRTD has become a major driving force on campus and is ready to meet the challenges of moving new interventional strategies from bench to bedside.